The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
About this item
Full title
Author / Creator
The Huntington Study Group/ARC-HD Investigators and Coordinators , Frank, Samuel , Testa, Claudia , Edmondson, Mary C. , Goldstein, Jody , Kayson, Elise , Leavitt, Blair R. , Oakes, David , O’Neill, Christine , Vaughan, Christina , Whaley, Jacquelyn , Gross, Nicholas , Gordon, Mark Forrest and Savola, Juha-Matti
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
Deutetrabenazine is approved in the USA, China, Australia, Israel, Brazil, and South Korea for the treatment of chorea associated with Huntington disease.
Objective
We aimed to evaluate the long-term safety and tolerability of deutetrabenazine for the treatment of Huntington disease.
Methods
This open-label, single-arm, mu...
Alternative Titles
Full title
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9653309
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9653309
Other Identifiers
ISSN
1172-7047
E-ISSN
1179-1934
DOI
10.1007/s40263-022-00956-8
